norethindrone has been researched along with promegestone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Doré, JC; Gilbert, J; Ojasoo, T; Raynaud, JP | 1 |
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Jeng, MH; Jordan, VC | 1 |
| Band, V; Farooq, A; Kharbanda, SM; Murugesan, K | 1 |
| Mazella, J; Sun, B; Tseng, L | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Greyling, MD; Potgieter, HC; van Aarde, RJ | 1 |
| Bouchoux, F; Degryse, M; Gaillard, M; Lecaque, D; Petit, F; Philibert, D | 1 |
| Al-Azzawi, F; Thompson, J; Wahab, M | 1 |
| al-Azzawi, F; Dillon, J; Hirvonen, E; Magaril, C; Pornel, B; Thompson, J; van der Mooren, MJ; Wahab, M; Ylikorkala, O | 1 |
| García-Becerra, R; Gutiérrez-Sagal, R; Pasapera, AM; Savouret, JF; Ulloa-Aguirre, A | 1 |
| Dehennin, L; Jondet, M | 1 |
| Al-Azzawi, F; Proudler, AJ; Sami, S; Stevenson, J; Thompson, J; Wahab, M | 1 |
| Shirk, RA; Winneker, RC; Zhang, Z | 1 |
| Gambacciani, M; Genazzani, AR; Spielmann, D | 1 |
| Pornel, B; Spielmann, D | 1 |
| Koninckx, PR; Spielmann, D | 1 |
| Bouchard, P; De Cicco-Nardone, F; Garcea, N; Spielmann, D | 1 |
7 trial(s) available for norethindrone and promegestone
| Article | Year |
|---|---|
Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis.
Topics: Adult; Antigens, CD34; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Female; Hormone Replacement Therapy; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Postmenopause; Progestins; Promegestone; Reference Values | 2000 |
Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
Topics: Argentina; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2001 |
Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; England; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone | 2004 |
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
Topics: Administration, Oral; Adult; Affect; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sweating | 2005 |
A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sleep Wake Disorders; Sweating; Uterine Hemorrhage | 2005 |
A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Uterine Hemorrhage | 2005 |
Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women.
Topics: Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Humans; Israel; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2005 |
13 other study(ies) available for norethindrone and promegestone
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
Topics: Animals; Cells, Cultured; Enzyme Induction; Glucocorticoids; Male; Rabbits; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Receptors, Steroid; Steroids; Tyrosine Transaminase | 1988 |
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Estradiol; Gene Expression Regulation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 1991 |
Modulation of steroid production in goat ovarian cells: effect of progestins and antiprogestins.
Topics: Androstenedione; Androstenols; Animals; Corpus Luteum; Estradiol; Estrenes; Female; Follicle Stimulating Hormone; Gestrinone; Goats; Granulosa Cells; Nandrolone; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Promegestone | 1990 |
Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
Topics: Adult; Aromatase; Dexamethasone; Dose-Response Relationship, Drug; Endometrium; Estrenes; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Norethindrone; Progesterone; Progestins; Promegestone; Steroids; Tamoxifen; Testosterone; Time Factors | 1986 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Ligand specificity of uterine oestrogen and progesterone receptors in the subadult African elephant, Loxodonta africana.
Topics: Animals; Binding, Competitive; Elephants; Female; Hormone Antagonists; Ligands; Mifepristone; Norethindrone; Progesterone; Progesterone Congeners; Promegestone; Protein Binding; Radioligand Assay; Receptors, Estrogen; Receptors, Progesterone; Sexual Maturation; Tritium | 1997 |
The pharmacological profile of a novel norpregnance progestin (trimegestone).
Topics: Administration, Oral; Administration, Topical; Animals; Binding, Competitive; Endometrium; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone; Mice; Norethindrone; Norpregnenes; Progesterone Congeners; Promegestone; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Specific Pathogen-Free Organisms; Uterus | 1999 |
Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
Topics: Animals; Binding, Competitive; Cell Line; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Estrogens; Gene Expression; Genes, Reporter; Genetic Vectors; Kidney; Levonorgestrel; Mifepristone; Norethindrone; Norpregnenes; Progestins; Promegestone; Promoter Regions, Genetic; Rabbits; Receptors, Progesterone; Response Elements; Transcriptional Activation; Transfection | 2001 |
Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis-morphometric study.
Topics: Administration, Cutaneous; Administration, Intranasal; Case-Control Studies; Chlormadinone Acetate; Drug Administration Schedule; Endometrium; Estradiol; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Microcirculation; Middle Aged; Norethindrone; Postmenopause; Progesterone; Promegestone | 2003 |
Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Topics: Androstenes; Animals; Antithrombins; Blood Coagulation; Cholesterol; Estrogens; Ethinyl Estradiol; Female; Humans; Lipoproteins; Models, Animal; Norethindrone; Norethindrone Acetate; Norethynodrel; Ovariectomy; Progestins; Promegestone; Rats; Rats, Sprague-Dawley | 2005 |